Clincosm LogoSign in Get a demo

The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory Diseases

Sponsor
Jonsson Comprehensive Cancer Center (Other)
Overall Status
Completed
CT.gov ID
NCT01180907
Collaborator
(none)
10
Enrollment
1
Location

Study Details

Study Description

Brief Summary

The purpose of the study is to determine whether positron emission tomography using the new imaging agent 18F-FAC can be used for imaging cancer and/or inflammation.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    10 participants
    Official Title:
    The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory Diseases: A Pilot Study
    Study Start Date :
    Nov 1, 2007
    Actual Primary Completion Date :
    Nov 1, 2011

    Arms and Interventions

    Arm Intervention/Treatment
    patients with cancer
    patients with autoimmune diseases
    healthy subjects

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      Yes
      Inclusion Criteria:

      • 18 years of age

      • women of childbearing potential will undergo a pregnancy test free of charge

      • patients with cancer or autoimmune diseases or healthy subjects

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 UCLA Los Angeles California United States 90095

      Sponsors and Collaborators

      • Jonsson Comprehensive Cancer Center

      Investigators

      • Principal Investigator: Christiaan Schiepers, M.D. Ph.D, University of California, Los Angeles

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      Jonsson Comprehensive Cancer Center
      ClinicalTrials.gov Identifier:
      NCT01180907
      Other Study ID Numbers:
      • 07-07-071
      • DE-PS02-08ER-08-01
      • CIRMNo. RT1-01126-1
      • 10-000269
      First Posted:
      Aug 12, 2010
      Last Update Posted:
      Jul 31, 2012
      Last Verified:
      Jul 1, 2012
      Keywords provided by Jonsson Comprehensive Cancer Center
      18F-FAC
      imaging
      cancer
      inflammation
      PET
      Additional relevant MeSH terms:
      Inflammation

      Study Results

      No Results Posted as of Jul 31, 2012